Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00635362 · ClinicalTrials.gov registry record · NA
Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00635362 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 42 participants.
The verdict
NCT00635362, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The study is a randomized controlled trial comparing outcomes of immediate postplacental insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) vs. interval insertion of the LNG-IUS performed 4-8 weeks after delivery for patients undergoing scheduled cesarean delivery. Our primary hypothesis is that the proportion of women using the LNG-IUS for contraception at 12 months after delivery will be higher in the group randomized to immediate post-placental insertion.
Interventions
- DEVICE Levonorgestrel-releasing intrauterine system (LNG-IUS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2007-05 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00635362
The ClinicalTrials.gov registry entry for NCT00635362 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel-releasing intrauterine system (LNG-IUS) is the first listed.
NCT00635362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00635362 about?
NCT00635362 is a clinical study titled "Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion". The study is a randomized controlled trial comparing outcomes of immediate postplacental insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) vs. interval insertion of the LNG-IUS performed 4-8 weeks after delivery for patients undergoing scheduled cesarean delivery. Our primary ...
What is the current status of trial NCT00635362?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2007-05. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00635362?
The interventions under investigation include: Levonorgestrel-releasing intrauterine system (LNG-IUS) (DEVICE).
Who is sponsoring clinical trial NCT00635362?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.